As pituitary function depends on the integrity of the hypothalamic-pituitar
y axis, any defect in the development and organogenesis of this gland may a
ccount for a form of combined pituitary hormone deficiency (CPHD). Although
pit-1 was 1 of the first factors identified as a cause of CPHD in mice, ma
ny other homeodomain and transcription factors have been characterized as b
eing involved in differ ent developmental stages of pituitary gland develop
ment, such as prophet of pit-1 (prop-1), P-Lim, ETS-1, and Brn 4. The aims
of the present study were first to screen families and patients suffering f
rom different forms of CPHD for PROP1 gene alterations, and second to defin
e possible hot spots and the frequency of the different gene alterations fo
und. Of 73 subjects (36 families) analyzed, we found 35 patients, belonging
to 18 unrelated families, with CPHD caused by a PROP1 gene defect. The PRO
P1 gene alterations included 3 missense mutations, 2 frameshift mutations,
and 1 splice site mutation. The 2 reported frameshift mutations could be ca
used by any 2-bp GA or AG deletion at either the 148-GGA-GGG-153 or 295-CGA
-GAG-AGT-303 position. As any combination of a GA or AG deletion yields the
same sequencing data, the frameshift mutations were called 149delGA and 29
6delGA, respectively. All but 1 mutation were located in the PROP1 gene enc
oding the homeodomain. Importantly, 3 tandem repeats of the dinucleotides G
A at location 296-302 in the PROP1 gene represent a hot spot for CPHD. In c
onclusion, the PROP1 gene seems to be a major candidate gene for CPHD; howe
ver, further studies are needed to evaluate other genetic defects involved
in pituitary development.